Jasper Therapeutics stockholders approve 2024 equity plans; amended employment agreements for CEO and other executives

Jasper Therapeutics, Inc.

Stockholders voted 10.3M for, 95K against to approve 2024 Equity Incentive Plan.
Stockholders voted 10.4M for, 12K against to approve 2024 Employee Stock Purchase Plan.
CEO Martell's annual salary remains $727,272; target bonus 50% of base; severance 18 months base plus COBRA.
CFO Cross salary $476,100; COO Mahal $481,301; CMO Tucker $514,500; each target bonus 45% of base.
Company terminated prior severance plan in favor of individual employment agreements.

item 5.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-24-051891
form_type: 8-K
ticker: JSPR
cik: 0001788028
company_name: Jasper Therapeutics, Inc.
filed_at: 2024-06-12T23:59:59+00:00
discovered_at: 2026-05-14T18:03:20.120527+00:00
generated_at: 2026-06-01T04:52:41.068877+00:00
sec_items: ["5.02", "5.07", "9.01"]
event_type: other
sentiment: neutral
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-24-051891
json_url: https://secwatch.observer/filing/0001213900-24-051891.json
markdown_url: https://secwatch.observer/filing/0001213900-24-051891.md
text_url: https://secwatch.observer/filing/0001213900-24-051891.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1788028/000121390024051891/0001213900-24-051891-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1788028/000121390024051891/ea0207631-8k_jasper.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

ONDS

Ondas shareholders approve increase in authorized shares to 1.2B and stock plan pool to 81M shares

Ondas Inc. May 28, 2026, 4:09 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

FLUT

Flutter shareholders approve 7 of 8 AGM proposals; preferred share amendment fails

Flutter Entertainment plc May 29, 2026, 5:34 PM ET other Items 5.03, 5.07, 7.01, 9.01

same SEC item: 5.07, 9.01 same event type: other similar materiality

Filing page SEC filing

SCYX

SCYNEXIS effects 1:8 reverse stock split; authorized shares cut to 18.75M

SCYNEXIS INC May 29, 2026, 4:01 PM ET other Items 5.03, 9.01

same SEC item: 9.01 same event type: other similar materiality

Filing page SEC filing

EDSA

Edesa Biotech shareholders approve equity plan amendment adding 750K shares

Edesa Biotech, Inc. May 29, 2026, 4:15 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other

Filing page SEC filing

HAFC

Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP

HANMI FINANCIAL CORP May 27, 2026, 6:15 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other

Filing page SEC filing

XBP

XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay

XBP Global Holdings, Inc. June 1, 2026, 5:00 PM ET other Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other

Filing page SEC filing

AXON

Axon shareholders elect all 9 director nominees and approve say-on-pay at 2026 annual meeting

AXON ENTERPRISE, INC. June 1, 2026, 4:10 PM ET other Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other

Filing page SEC filing

NRGV

Energy Vault shareholders elect three Class II directors and ratify BDO USA as auditor

Energy Vault Holdings, Inc. June 1, 2026, 11:36 AM ET other Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other

Filing page SEC filing

Source: SEC EDGAR

accession 0001213900-24-051891

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.